Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
Donghoon Shin,1 Younju Lee,1 Deokyoon Jeong,1 Rod Ellis-Pegler2 1Samsung Bioepis Co. Ltd, Incheon, Republic of Korea; 2Auckland Clinical Studies, Ltd., Auckland, New Zealand Purpose: The objective of this study was to demonstrate comparable pharmacokinetic (PK), safety, and tolerability parameters...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-11-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/comparative-pharmacokinetics-of-an-adalimumab-biosimilar-sb5-administe-peer-reviewed-article-DDDT |